163 related articles for article (PubMed ID: 14667436)
1. Cortical-area specific block of genetically determined absence seizures by ethosuximide.
Manning JP; Richards DA; Leresche N; Crunelli V; Bowery NG
Neuroscience; 2004; 123(1):5-9. PubMed ID: 14667436
[TBL] [Abstract][Full Text] [Related]
2. The effects of ethosuximide on amino acids in genetic absence epilepsy rat model.
Terzioğlu B; Aypak C; Onat FY; Küçükibrahimoğlu E; Ozkaynakçi AE; Gören MZ
J Pharmacol Sci; 2006 Mar; 100(3):227-33. PubMed ID: 16538026
[TBL] [Abstract][Full Text] [Related]
3. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy.
Richards DA; Manning JP; Barnes D; Rombola L; Bowery NG; Caccia S; Leresche N; Crunelli V
Epilepsy Res; 2003 May; 54(2-3):97-107. PubMed ID: 12837561
[TBL] [Abstract][Full Text] [Related]
4. Localized cortical injections of ethosuximide suppress spike-and-wave activity and reduce the resistance to kindling in genetic absence epilepsy rats (GAERS).
Gülhan Aker R; Tezcan K; Carçak N; Sakalli E; Akin D; Onat FY
Epilepsy Res; 2010 Mar; 89(1):7-16. PubMed ID: 19939632
[TBL] [Abstract][Full Text] [Related]
5. Ethosuximide converts ictogenic neurons initiating absence seizures into normal neurons in a genetic model.
Polack PO; Charpier S
Epilepsia; 2009 Jul; 50(7):1816-20. PubMed ID: 19260940
[TBL] [Abstract][Full Text] [Related]
6. Effect of intracranial administration of ethosuximide in rats with spontaneous or pentylenetetrazol-induced spike-wave discharges.
Chen SD; Yeh KH; Huang YH; Shaw FZ
Epilepsia; 2011 Jul; 52(7):1311-8. PubMed ID: 21729038
[TBL] [Abstract][Full Text] [Related]
7. The effect of chronic treatment with sodium channel blocker lacosamide on early development of absence seizures in genetic absence epilepsy rats.
Çarçak N; Karanfil C; Akat Ş; Akman Ö; Onat F
Epilepsy Res; 2022 May; 182():106896. PubMed ID: 35286866
[TBL] [Abstract][Full Text] [Related]
8. Higher-order thalamic nuclei facilitate the generalization and maintenance of spike-and-wave discharges of absence seizures.
Atherton Z; Nagy O; Barcsai L; Sere P; Zsigri N; Földi T; Gellért L; Berényi A; Crunelli V; Lőrincz ML
Neurobiol Dis; 2023 Mar; 178():106025. PubMed ID: 36731682
[TBL] [Abstract][Full Text] [Related]
9. Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model.
van Raay L; Jovanovska V; Morris MJ; O'Brien TJ
Epilepsia; 2012 Mar; 53(3):477-84. PubMed ID: 22220638
[TBL] [Abstract][Full Text] [Related]
10. Effect of systemic and intracortical administration of phenytoin in two genetic models of absence epilepsy.
Gurbanova AA; Aker R; Berkman K; Onat FY; van Rijn CM; van Luijtelaar G
Br J Pharmacol; 2006 Aug; 148(8):1076-82. PubMed ID: 16865096
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the somatosensory cortex prevents paroxysmal oscillations in cortical and related thalamic neurons in a genetic model of absence epilepsy.
Polack PO; Mahon S; Chavez M; Charpier S
Cereb Cortex; 2009 Sep; 19(9):2078-91. PubMed ID: 19276326
[TBL] [Abstract][Full Text] [Related]
12. Anti-absence activity of mGlu1 and mGlu5 receptor enhancers and their interaction with a GABA reuptake inhibitor: Effect of local infusions in the somatosensory cortex and thalamus.
D'Amore V; von Randow C; Nicoletti F; Ngomba RT; van Luijtelaar G
Epilepsia; 2015 Jul; 56(7):1141-51. PubMed ID: 26040777
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of unilateral- versus bilateral-onset spike-wave discharges to ethosuximide and carbamazepine in the fluid percussion injury rat model of traumatic brain injury.
Tatum S; Smith ZZ; Taylor JA; Poulsen DJ; Dudek FE; Barth DS
J Neurophysiol; 2021 Jun; 125(6):2166-2177. PubMed ID: 33949882
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes of GABA immunoreactivity in cortico-thalamic networks of an absence seizure model.
Bombardi C; Venzi M; Crunelli V; Di Giovanni G
Neuropharmacology; 2018 Jul; 136(Pt A):56-67. PubMed ID: 29471054
[TBL] [Abstract][Full Text] [Related]
15. Sensory coding is impaired in rat absence epilepsy.
Studer F; Laghouati E; Jarre G; David O; Pouyatos B; Depaulis A
J Physiol; 2019 Feb; 597(3):951-966. PubMed ID: 30548850
[TBL] [Abstract][Full Text] [Related]
16. Effect of U-92032, T-Type Ca2+ Channel Blocker, on Rats with Genetic Absence Epilepsy.
Yananli HR; Demirkapu MJ; Sakallı HE; Gülhan R; Onat FY
Pharmacology; 2020; 105(9-10):561-567. PubMed ID: 32101873
[TBL] [Abstract][Full Text] [Related]
17. Nucleus-specific abnormalities of GABAergic synaptic transmission in a genetic model of absence seizures.
Bessaïh T; Bourgeais L; Badiu CI; Carter DA; Toth TI; Ruano D; Lambolez B; Crunelli V; Leresche N
J Neurophysiol; 2006 Dec; 96(6):3074-81. PubMed ID: 16971676
[TBL] [Abstract][Full Text] [Related]
18. T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy.
Broicher T; Seidenbecher T; Meuth P; Munsch T; Meuth SG; Kanyshkova T; Pape HC; Budde T
Neuropharmacology; 2007 Sep; 53(3):431-46. PubMed ID: 17675191
[TBL] [Abstract][Full Text] [Related]
19. Termination of ongoing spike-wave discharges investigated by cortico-thalamic network analyses.
Lüttjohann A; Schoffelen JM; van Luijtelaar G
Neurobiol Dis; 2014 Oct; 70():127-37. PubMed ID: 24953875
[TBL] [Abstract][Full Text] [Related]
20. Peri-ictal network dynamics of spike-wave discharges: phase and spectral characteristics.
Lüttjohann A; Schoffelen JM; van Luijtelaar G
Exp Neurol; 2013 Jan; 239():235-47. PubMed ID: 23124095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
